Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12583945 | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof | 🖼🧊📄§ | 2026-03-24 | 2043-11-17 | 0 | 31 |
| 12584101 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | 🖼🧊📄§ | 2026-03-24 | 2043-09-22 | 0 | 31 |
| 12583892 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12583890 | Methods for control of an infective disease with a vaccine | 🖼🧊📄§ | 2026-03-24 | 2042-09-20 | 0 | 31 |
| 12583888 | Bi-specific extracellular matrix binding peptides and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12583815 | Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-02 | 0 | 31 |
| 12583821 | Salt of omecamtiv mecarbil and process for preparing salt | 🖼🧊📄§ | 2026-03-24 | 2044-01-24 | 0 | 31 |
| 12583848 | Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12583850 | Small molecule antiviral drug treatment for human papillomavirus infections | 🖼🧊📄§ | 2026-03-24 | 2045-08-07 | 0 | 31 |
| 12583857 | Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines | 🖼🧊📄§ | 2026-03-24 | 2043-12-21 | 0 | 31 |
| 12583865 | Biologically active taxane analogs and methods of treatment by oral administration | 🖼🧊📄§ | 2026-03-24 | 2043-09-27 | 0 | 31 |
| 12583867 | Pyridone derivative crystal form and preparation method and application therefor | 🖼🧊📄§ | 2026-03-24 | 2039-11-05 | 0 | 31 |
| 12584105 | Autologous cell replacement therapy for Parkinson's disease | 🖼🧊📄§ | 2026-03-24 | 2040-05-21 | 0 | 31 |
| 12582694 | Compounds and methods for inhibiting protozoan parasites | 🖼🧊📄§ | 2026-03-24 | 2042-05-12 | 0 | 31 |
| 12582612 | Pharmaceutical composition of Siglec-binding agents | 🖼🧊📄§ | 2026-03-24 | 2041-10-05 | 0 | 31 |
| 12582599 | Methods for treatment of bladder cancer with gemcitabine | 🖼🧊📄§ | 2026-03-24 | 2042-07-07 | 0 | 31 |
| 12584149 | Nuclease-mediated genome editing of primary cells and related kits | 🖼🧊📄§ | 2026-03-24 | 2042-12-05 | 0 | 31 |
| 12583912 | Flavivirus cross neutralizing antibody and pharmaceutical composition | 🖼🧊📄§ | 2026-03-24 | 2041-02-04 | 0 | 31 |
| 12583907 | Modified plasma clotting factor VIII and method of use thereof | 🖼🧊📄§ | 2026-03-24 | 2043-09-15 | 0 | 31 |
| 12583904 | Articles of manufacture and methods for treatment using adoptive cell therapy | 🖼🧊📄§ | 2026-03-24 | 2044-09-11 | 0 | 31 |
| 12583939 | Bispecific antigen binding molecules that bind HER2, and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2044-03-08 | 0 | 31 |
| 12583917 | IL17A antibodies and antagonists for veterinary use | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12582714 | Methods and compositions for freezing and thawing mammalian cells | 🖼🧊📄§ | 2026-03-24 | 2043-07-28 | 0 | 31 |
| 12583921 | Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-04-26 | 0 | 31 |
| 12582956 | Articles of manufacture with polyurea capsules cross-linked with chitosan | 🖼🧊📄§ | 2026-03-24 | 2041-02-12 | 0 | 31 |
| 12582720 | Compound for preventing or treating lipid metabolism-related diseases | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |
| 12584114 | Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse | 🖼🧊📄§ | 2026-03-24 | 2044-01-03 | 0 | 31 |
| 12583896 | Caged-degron-based molecular feedback circuits and methods of using the same | 🖼🧊📄§ | 2026-03-24 | 2040-01-06 | 0 | 31 |
| 12582212 | Mesh-type moisture-release cushion cosmetic product | 🖼🧊📄§ | 2026-03-24 | 2039-10-08 | 0 | 31 |
| 12583873 | Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same | 🖼🧊📄§ | 2026-03-24 | 2038-11-26 | 0 | 31 |
| 12582650 | IRAK4 kinase inhibitor and preparation method therefor | 🖼🧊📄§ | 2026-03-24 | 2040-07-24 | 0 | 31 |
| 12582666 | Low dose therapeutic treatment | 🖼🧊📄§ | 2026-03-24 | 2043-10-12 | 0 | 31 |
| 12583900 | Peptide conjugates and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-12-03 | 0 | 31 |
| 12582626 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-07 | 0 | 31 |
| 12583882 | Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates | 🖼🧊📄§ | 2026-03-24 | 2042-08-08 | 0 | 31 |
| 12582619 | Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections | 🖼🧊📄§ | 2026-03-24 | 2041-03-30 | 0 | 31 |
| 12582614 | Composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12584146 | Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines | 🖼🧊📄§ | 2026-03-24 | 2045-04-18 | 0 | 31 |
| 12582613 | Biomimetic, reactive oxygen species-detonable nanoclusters for antirestenotic therapy | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582652 | 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator | 🖼🧊📄§ | 2026-03-24 | 2044-10-25 | 0 | 31 |
| 12582670 | Lignin solvation using aqueous biologically compatible buffers | 🖼🧊📄§ | 2026-03-24 | 2040-01-10 | 0 | 31 |
| 12582723 | Polynucleotides encoding a human FKRP protein | 🖼🧊📄§ | 2026-03-24 | 2043-03-02 | 0 | 31 |
| 12582672 | Vanadium compositions and methods for treatment of cancer | 🖼🧊📄§ | 2026-03-24 | 2039-11-13 | 0 | 31 |
| 12582685 | Uses of saccharides from prasinococcales | 🖼🧊📄§ | 2026-03-24 | 2041-07-27 | 0 | 31 |
| 12582680 | Pharmaceutical composition for prevention, amelioration, or treatment of skin disease | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12582676 | Hydrogel particle encapsulated viable cells for in vivo regenerative treatment | 🖼🧊📄§ | 2026-03-24 | 2043-07-18 | 0 | 31 |
| 12582662 | Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative | 🖼🧊📄§ | 2026-03-24 | 2043-05-26 | 0 | 31 |
| 12582725 | AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease | 🖼🧊📄§ | 2026-03-24 | 2040-06-03 | 0 | 31 |
| 12582696 | Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease | 🖼🧊📄§ | 2026-03-24 | 2040-12-10 | 0 | 31 |
| 12582697 | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure | 🖼🧊📄§ | 2026-03-24 | 2039-06-26 | 0 | 31 |